- Investigator
- James Wymer
- Status
- Accepting Candidates
About me
My name is Dr. James Wymer, I'm a neurologist and professor practicing at the University of Florida. I specialize in diagnosis and management of neuromuscular diseases, including amyotrophic lateral sclerosis (ALS) or Lou Gehrig鈥檚 disease, muscle diseases, and peripheral neuropathies. I have extensive experience in clinical research, having been a principal investigator on numerous clinical trials, including studies of ALS, diabetic neuropathy, multiple sclerosis, migraine headaches, and epilepsy. I am a fellow of the American Academy of Neurology (AAN) and the American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM), as well as a member of several national consortiums to research neuropathic pain and ALS.
My clinical interests include: 鈥� ALS or Lou Gehrig's Disease 鈥� Neuromuscular diseases 鈥� Hereditary Neuropathy 鈥� Muscle disease 鈥� Multiple Sclerosis 鈥� Diabetic neuropathy 鈥� Migraine headaches 鈥� Neurofibromatosis
My Locations
Active clinical trials
The purpose of this study is to evaluate the efficacy, safety, tolerability and pharmacokinetics of NMD670 in the treatment of ambulatory adults with spinal muscular atrophy type 3
- Investigator
- James Wymer
- Status
- Accepting Candidates
- Ages
- 18 Years - 75 Years
- Sexes
- All
The HEALEY ALS Platform Trial is a perpetual multi-center, multi-regimen clinical trial evaluating the safety and efficacy of investigational products for the treatment of ALS.
- Investigator
- James Wymer
- Status
- Accepting Candidates
- Ages
- 18 Years - N/A
- Sexes
- All
My research
Top areas of exploration
- Amyotrophic Lateral Sclerosis , 32 publications
- Deglutition Disorders , 12 publications
- Deglutition , 11 publications
- Cough , 6 publications
Research activity
Accepted insurances
Please note: Some physicians and practices might not accept a specific insurance plan. Our list is also subject to change, and sometimes that change is not yet reflected in this list. Please contact the practice to confirm that your insurance is accepted. A representative will be happy to assist you.
See all insurancesMy areas of focus
Stories and news
New study shows common diabetes drug improves symptoms in genetic form of ALS in mice
July 20, 2020
New preclinical research shows a commonly used Type 2 diabetes drug can improve symptoms in a specific genetic form of ALS and frontotemporal dementia in mice.鈥�
Department of Molecular Genetics and Microbiology, Department of Neurology, Department of Pathology, Immunology, and Laboratory Medicine, +4 more
